Establishing a standardized system for review and adjudication of chronic graft‐vs‐host disease data in accordance with the National Institutes Consensus criteria
D Dierov, N Webb, S Fatmi, C Nwanne… - Advances in cell and …, 2019 - Wiley Online Library
Graft‐vs‐host Disease (GVHD) is a frequent complication following allogeneic stem cell
transplantation (allo‐HCT). The National Institute of Health consensus group established …
transplantation (allo‐HCT). The National Institute of Health consensus group established …
[HTML][HTML] Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
Background/purpose Patients with acute leukemia undergoing allogeneic hematopoietic
stem cell transplantation (allo-HSCT) are exposed to high risk of developing invasive fungal …
stem cell transplantation (allo-HSCT) are exposed to high risk of developing invasive fungal …
Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
J Tan, Y Wang, SJ Yu, YY Ma, HY Lei, QF Liu - Leukemia Research, 2017 - Elsevier
The cure of acute leukemia by allogeneic hematopoietic stem cell transplantation (allo-
HSCT) is closely linked to major complications leading to adverse outcomes, including graft …
HSCT) is closely linked to major complications leading to adverse outcomes, including graft …
[HTML][HTML] Addition of anti-thymocyte globulin in allogeneic stem cell transplantation with peripheral stem cells from matched unrelated donors improves graft-Versus …
MM Ali, B Grønvold, M Remberger… - … Myeloma and Leukemia, 2021 - Elsevier
Anti-thymocyte globulin (ATG) is commonly used to prevent graft-versus-host disease
(GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To evaluate …
(GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To evaluate …
[HTML][HTML] European Group for Blood and Marrow Transplantation risk score predicts the outcome of patients with acute leukemia receiving single umbilical cord blood …
X Zhu, L Huang, C Zheng, B Tang, H Liu, L Geng… - Biology of Blood and …, 2017 - Elsevier
Abstract The European Group for Blood and Marrow Transplantation (EBMT) risk score has
been implemented as an important tool to predict patient outcomes after allogeneic …
been implemented as an important tool to predict patient outcomes after allogeneic …
[HTML][HTML] Assessment of individual versus composite endpoints of acute graft-versus-host disease in determining long-term survival after allogeneic transplantation
J Magenau, T Braun, E Gatza, T Churay… - Biology of Blood and …, 2019 - Elsevier
The overall composite of graft-versus-host disease (GVHD)-free, relapse-free survival
(GRFS), defined as survival free of grade III-IV acute GVHD (aGVHD), chronic GVHD …
(GRFS), defined as survival free of grade III-IV acute GVHD (aGVHD), chronic GVHD …
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival
F Spina, T Radice, C De Philippis… - Leukemia & …, 2019 - Taylor & Francis
This monocentric retrospective study included 70 consecutive relapsed/refractory Hodgkin
lymphoma (RR-HL) patients receiving reduced-intensity allogeneic stem cell transplantation …
lymphoma (RR-HL) patients receiving reduced-intensity allogeneic stem cell transplantation …
Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15
Y Xiong, M Mouginot, L Reppel, C Qian, J Stoltz… - Immunologic …, 2017 - Springer
The ability of natural killer (NK) cells to kill tumor cells without antigen recognition makes
them appealing as an adoptive immunotherapy. However, NK cells are not routinely used in …
them appealing as an adoptive immunotherapy. However, NK cells are not routinely used in …
Pretransplant serum fibrinogen level may be a predictive marker on chronic graft-versus-host disease (cgvhd) in patients having undergone allogeneic hematopoietic …
© 2022, UHOD-Uluslararasi Hematoloji Onkoloji Dergisi. All rights reserved. Inflammatory
processes play an important role in the pathophysiology of cGVHD. Serum fibrinogen is a …
processes play an important role in the pathophysiology of cGVHD. Serum fibrinogen is a …
European Group for Blood and Marrow Transplantation score correlates with outcomes of older patients undergoing allogeneic hematopoietic stem cell …
Background: Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are
hematological diseases predominantly occurring in older patients. Although allogeneic …
hematological diseases predominantly occurring in older patients. Although allogeneic …